Gene microarray technology provides an efficient way to diagnose cancer. However, microarray gene expression data face the challenges of high-dimension, small-sample, and multi-class imbalance. The ...
SHENZHEN, China, Oct. 2, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, introduced a significant development—Multi-Class ...
SHENZHEN, China, Nov. 14, 2025 /PRNewswire/ -- MicroCloud Hologram Inc. (NASDAQ: HOLO), ("HOLO" or the "Company"), a technology service provider, has launched a groundbreaking technological ...